financetom
Business
financetom
/
Business
/
What's Going On With SelectQuote Stock Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With SelectQuote Stock Tuesday?
Feb 11, 2025 9:39 AM

SelectQuote, Inc ( SLQT ). stock is trading higher on Tuesday after the company reported better-than-expected 2025 fiscal-year second-quarter earnings on Monday after the market closed.

The Details: SelectQuote ( SLQT ) reported earnings per share of 30 cents, beating analysts’ estimate of 10 cents. In addition, the company reported sales of $481.07 million, beating analysts’ estimate of $447.00 million.

SelectQuote ( SLQT ) further broke down its revenue, reporting $255.6 million from the senior segment, $183.4 million from the healthcare services segment and $39.9 million from the life segment. Also, the company reported adjusted EBITDA of $87.5 million and net income of $53.2 million.

“SelectQuote delivered impressive results during our fiscal second quarter despite a historically disruptive Annual Enrollment Period,” said Tim Danker, CEO of SelectQuote ( SLQT ).

“Our strong policy volume and Senior Adjusted EBITDA margin of 39%, up approximately 750 basis points year-over-year, are additional proof points of our differentiated, high-touch, agent-led model. American Seniors faced an unprecedented level of plan terminations and benefit changes this season, and we take great pride in that fact that consumers sought out SelectQuote ( SLQT ) as they navigated such a challenging market backdrop.”

The company issued guidance for the 2025 fiscal year. It sees revenue from $1.5 billion to $1.57 billion, versus analysts’ estimate of $1.46 billion. Furthermore, the company projects adjusted EBITDA from $115 million to $140 million.

Additionally, the company announced a $350 million strategic investment from Bain Capital, Morgan Stanley Private Credit and Newlight Partners. The investment supports continued growth in its healthcare services business, strengthens partnerships with carriers and offers more value to consumers as a result. It will help recapitalize the balance sheet, reduce annual debt service and provide liquidity to fund growth initiatives.

Related Link: KKR Raises Bid In Fierce Takeover Battle Of Fuji Soft, Bain Weighs Next Steps: Report

SLQT Price Action: At the time of writing, SelectQuote ( SLQT ) stock is trading 26.9% higher at $5.56, according to data from Benzinga Pro.

Image: via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Palantir, Anduril sign partnership for AI training in defense
Palantir, Anduril sign partnership for AI training in defense
Dec 6, 2024
(Reuters) - Data analytics firm Palantir Technologies ( PLTR ) and defense tech company Anduril Industries have partnered to use defense data for artificial intelligence training, the companies said on Friday. The partnership will leverage Palantir's ( PLTR ) AI platform to structure, label and prepare defense data for training to deploy those models onto national security systems, while Anduril's...
NeuroSense Therapeutics Files Prospectus for Secondary Stock Sale
NeuroSense Therapeutics Files Prospectus for Secondary Stock Sale
Dec 6, 2024
05:03 PM EST, 12/06/2024 (MT Newswires) -- NeuroSense Therapeutics ( NRSN ) late Friday disclosed plans by one of its larger institutional investors to sell a portion of its stake in the biotechnology company from time to time. The company filed a preliminary prospectus Friday for Rimon Gold Assets to sell up to 11 million of its NeuroSense ordinary shares,...
US court upholds ruling allowing sanctions prosecution of Turkey's Halkbank
US court upholds ruling allowing sanctions prosecution of Turkey's Halkbank
Dec 6, 2024
NEW YORK, Dec 6 (Reuters) - A U.S. appeals court on Friday declined to reconsider its ruling allowing the federal government to prosecute Turkey's Halkbank on charges it helped Iran evade American sanctions. A three-judge panel of the 2nd U.S. Circuit Court of Appeals in October rejected the Turkish lender's argument that it deserved immunity because it was state owned....
Centessa Pharmaceuticals Insider Sold Shares Worth $1,615,255, According to a Recent SEC Filing
Centessa Pharmaceuticals Insider Sold Shares Worth $1,615,255, According to a Recent SEC Filing
Dec 6, 2024
05:06 PM EST, 12/06/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on December 06, 2024, sold 87,496 shares in Centessa Pharmaceuticals ( CNTA ) for $1,615,255. Following the Form 4 filing with the SEC, Saha has control over a total of 613,661 shares of the company, with 575,661 shares held directly and 38,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1847903/000184790324000178/xslF345X05/wk-form4_1733522614.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved